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SCIENTIFIC CORRESPONDENCE
Clinical and morphological features including expression
of βig-h3 and keratan sulphate proteoglycans in
Maroteaux-Lamy syndrome type B and in normal cornea
Saeed Akhtar, Andrew Tullo, Bruce Caterson, Janet R Davies, Kelly Bennett,
Keith M Meek
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Br J Ophthalmol 2002;86:147–151
Aim: To carry out a detailed morphological study of the
cornea of a 16 year old female with a Maroteaux-Lamy
syndrome (MLS).
Methods: Following a penetrating keratoplasty in July
1999, ultrastructural changes in the cornea were
examined using electron microscopy. Proteoglycans were
visualised using cuprolinic blue dye; and βig-h3 and kera-
tan sulphate were detected by immunoelectron micros-
copy.
Results: The epithelial cells were degenerate and
contained apoptotic nuclei. Proteoglycans were present in
epithelial cells, intercellular spaces, and in swollen desmo-
somes. An abnormally large quantity of proteoglycans was
present throughout the stroma. Keratocytes throughout the
stroma had no cell organelles, were vacuolated, and con-
tained a large quantity of abnormal proteoglycans. Label-
ling for βig-h3 was intense around electron lucent spaces
in stroma. No labelling was seen in keratocytes or
endothelial cells. In normal cornea, keratan sulphate label-
ling was regular throughout the stroma. In MLS VI type B
cornea, keratan sulphate labelling was weak in the
anterior stroma but very intense in the posterior stroma and
in keratocyte lysosomes and vacuoles.
Conclusion: A deficiency of aryl sulfatase B results in the
deposition of keratan sulphate proteoglycan and other
proteoglycans in lysosomes, causing the death of
keratocytes and an abnormal build-up of proteoglycans in
the stroma. This might be responsible for the lateral aggre-
gation of collagen fibrils and impaired fibrillogenesis in
MLS VI. Degenerate swollen keratocytes, together with
gross changes in epithelial, stromal, and endothelial cells,
would be expected to increase light scattering significantly
in these corneas.
Proteoglycans (PGs) form part of the corneal ground sub-stance, where they normally bind water and cations byvirtue of their polyanionic glycosaminoglycans (GAGs,
previously known as mucopolysaccharides). Normally, cornea
contains 4–4.5% GAG, of which 50% is keratan sulphate, 25%
is chondroitin sulphate, and 25% is chondroitin-4-sulphate; it
has recently been reported that there is no dermatan sulphate
present.1 Sulfatases catalyse the hydrolysis of sulphuric acid
esters from a wide variety of substrates, including GAGs, gly-
colipids and steroids. GAGs (dermatan, heparan, keratan, and
chondroitin sulphate) are byproducts of the catabolism of
proteoglycans located in the cell coat or extracellular matrix;
they are sequentially degraded in the lysosomal compartment
by specific hydrolases.2 As a result of a deficiency in enzyme
activities, partially degraded GAGs accumulate within second-
ary lysosomes. A deficiency in the specific lysosomal sulfatase,
which is involved in the degradation of GAGs, leads to rare
clinical disorders termed “mucopolysaccharidoses” (MPS).2–4
There are several MPS disorders recognised in humans, classi-
fied according to the specific deficiencies of the degradative
lysosomal enzyme. The primary clinical ocular manifestation
of the MPS diseases in humans and animals is corneal
opacification.5 6
The clinical characteristics of Maroteaux-Lamy syndrome
(MLS VI) are striking osseous and corneal changes without
intellectual impairment until late. Dermatan sulphate (for-
merly chondroitin sulphate B) is secreted in urine. In all forms
of the disease, leucocyte inclusions and a deficiency of aryl
sulfatase B (N-acetylgalactosamine 4-sulfatase) are found.
The stromal keratocytes and histocytes in MLS VI type B cor-
nea are full of vacuoles and lysosomes containing cell
organelle remnants.1 2 7–9
βig-h3 is an extracellular matrix protein that was first
detected in a human lung adenocarcinoma cell line after
stimulation by TGF-β.10 Recently, specific missense mutations
have been reported in the βig-h3 gene in four autosomal
dominant corneal dystrophies—lattice type I, granular,
Avellino, and Reis-Bücklers corneal stromal dystrophies.11
In the present paper, we report for the first time the
presence of keratan sulphate proteoglycan and βig-h3 protein
in epithelial cells, stroma, keratocytes, and endothelial cells in
the cornea of a patient with Maroteaux-Lamy syndrome and
in normal cornea.
METHODS
A patient was diagnosed as having MLS VI type B at 6 years of
age.When she was 15, she was referred because of rapid dete-
rioration of vision in both eyes as a result of corneal opacifica-
tion. Left penetrating keratoplasty was carried out in July
1999, resulting in a significant improvement in vision, and
allowing her return to normal schooling. However, 2 years
after surgery, although the graft remained clear, vision
deteriorated from optic nerve involvement due to raised
intracranial pressure. Corneal tissue was obtained at the time
of surgery. A normal corneal button was obtained 24 hours
post mortem from a cadaver donor.
Corneal tissue of MLS type B was fixed immediately after
excision in (i) 3% glutaraldehyde and 1% osmium tetroxide in
0.1 M phosphate buffer for morphological studies; (ii) 3% glu-
taraldehyde containing 0.05% cuprolinic blue (BDH Ltd, Dor-
set, UK) in a critical electrolyte concentration mode12 for pro-
teoglycan localisation (as described by Akhtar et al13); and (iii)
4% paraformaldehyde (PFA) in 0.1 M phosphate for 2 hours at
4°C and embedded at low temperature for immunoelectron
microscopy (as described by Akhtar et al14). Rabbit polyclonal
anti-human βig-h3 and mouse monoclonal anti-keratan
sulphate (MAb 5-D-4, B Caterson, Cardiff) were visualised
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with 10 nm immunogold conjugated anti-rabbit and anti-
mouse second antibodies, respectively (Biocell, Cardiff, UK).
RESULTS
MLS cornea: morphology
Light microscopic observations showed that the epithelium
was intact and thicker than in normal cornea (Fig 1A). Most
of the epithelial cells were degenerate and contained apoptotic
nuclei. Bowman’s layer was replaced by a fibrous pannus,
which contained vacuolated keratocytes (Fig 1A). Keratocytes
in the middle and posterior stroma were also vacuolated (Fig
1B, C). Endothelial cells were degenerate and contained
prominent nuclei (Fig 1C).
Electron microscopic observations showed that in the
epithelium apoptotic nuclei (90%) contained condensed
nuclear chromatin (Fig 2A) and blebbing in the nuclear mem-
brane (Fig 2B). Intercellular spaces were filled with electron
dense aggregates of PGs (Fig 2C). Most of the desmosomes
were swollen, degenerate, and full of electron dense material
(Fig 2D).
The PG filaments in the posterior stroma and, especially, in
pre-Descemet’s stroma (Fig 2E) were very large (approxi-
mately 200–240 nm), relative to the PG filaments (50–125 nm)
in the anterior stroma. Collagen fibres in the lamellae, which
contained keratocytes in extreme stages of degeneration, were
replaced by granular material and sparse collagen fibrils (Fig
2F). Throughout the stroma, the keratocytes were degenerate
and contained vacuoles and electron dense lysosomes (Fig
2F). These lysosomes were full of PG filaments, suggesting
their inability to digest these PGs (Fig 2G). Only a few kerato-
cytes had a prominent nucleus and rough endoplasmic reticu-
lum.
Expression of βig-h3 and keratan sulphate
In normal cornea samples, moderate labelling of βig-h3 was
observed throughout the cornea except keratocytes and
endothelial cells. In diseased tissue, moderate labelling of
βig-h3 was observed in the epithelium and in the normal
looking parts of Bowman’s layer. Labelling was dense on the
granular material around electron lucent spaces (Fig 3A) and
around the degenerate keratocytes (Fig 3B) present within the
sparse collagen lamellae.
In normal cornea, labelling of keratan sulphate (MAb
5-D-4) was regular throughout the stroma (Fig 4A). In MLS
corneal tissue, labelling of keratan sulphate was strong in
basal epithelial cells, which were vacuolated and contained
large quantities of PG filaments (as seen by cuprolinic blue
staining). In anterior stroma, labelling of keratan sulphate
was weak but very strong in posterior stroma. Labelling was
very dense and in clumps on degenerate collagen fibrils, on
fibrous material (Fig 4B) and around the electron lucent
spaces (Fig 4C). In normal corneal keratocytes labelling was
regular (Fig 4D), whereas in MLS tissue, vacuolated kerato-
cytes (Fig 4E) were strongly labelled in their lucent vacuoles
and on the electron dense material present in lysosomes (Fig
4E, F). Labelling was more dense in posterior keratocytes than
in anterior keratocytes. Endothelial cells also showed some
labelling (Fig 4G).
DISCUSSION
Our ultrastructural findings showed that in MLS corneal tis-
sue, the epithelium was degenerate and contained perinu-
clear vacuoles, and Bowman’s layer was replaced by
vacuolated histocytes. This was similar to the observations of
Kenyon et al7 but contrary to the observations of Mollard et
al,2 who found the epithelium normal. Neither authors
reported the presence of apoptotic nuclei in the epithelium,
which we observed in most of the epithelial cells. We found
degenerate keratocytes containing vacuolated inclusions
with substrate storage in secondary lysosomes. We identified
the storage material as proteoglycan and have shown for the
first time that the secondary lysosomes and electron lucent
vacuoles contain keratan sulphate. Proteoglycans were
present in large quantities throughout the stroma but the
cuprolinic blue stained filaments were relatively large (200
nm) in the posterior and pre-Descemet’s stroma. As reported
by others2 7 we noticed disorganised collagen lamellae but
unlike Kenyon et al7 we did not find any abnormal Descemet’s
membrane. Mollard et al2 suggested that the uniform spacing
between collagen fibrils implied a correctly functioning
endothelium, whereas Kenyon et al7 found the endothelium
to be vacuolated. The endothelium in our tissue was very
degenerate.
βig-h3 has been found in basement membrane of skin and
interstitial tissue.15 16 Recently, it has been localised immunohis-
tochemically in bullous keratopathy17 18 and corneal
dystrophies.19 In our case, the amount of βig-h3 was increased
as a result of the degeneration of the epithelium and because of
Figure 1 Clinical and light micrographs of MLS
cornea. (A) Degenerate epithelium (E) and fibrous
pannus (P) containing a vacuolated keratocyte
(KR); (B) vacuolated keratocytes (KR) in stroma (S);
(C) posterior part of the cornea showing
Descemet’s membrane (DM) and degenerate
endothelium (EN).
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the oedematous condition of stroma in which widening of
intercollagenous fibrillar spaces facilitates diffusion of macro-
molecules. βig-h3 is a protein of about 68 kD and therefore
similar in size to albumin. Maurice20 many years ago demon-
strated the ability of albumin to diffuse across the stroma.
In normal cornea, we found keratan sulphate labelling was
regular throughout the stroma, as reported by Bairaktaris et
al.21 Keratan sulphate labelling in MLS tissue was different
from that seen in normal cornea. In MLS tissue, vacuolated
epithelial cells which contained a large amount of proteogly-
can (shown by cuprolinic blue staining) were strongly labelled
for keratan sulphate. Only the posterior stroma showed very
strong labelling. In the keratocytes, keratan sulphate labelling
was highest in the lucent spaces and lysosomes.
MLS VI type B is a mucopolysaccharidosis that is a
lysosomal storage disease involving a deficiency in aryl sulfa-
tase B, which is the enzyme that removes the sulphate groups
from the GAGs that are endocytosed by the corneal cells over
time. This deficiency means that the sulphated GAGs, which
Figure 2 Electron micrographs of MLS cornea. (A) An apoptotic epithelial nucleus (N) with
condensed chromatin in an epithelial cell (E); (B) an apoptotic nucleus (N) with prominent
blebbing in an epithelial cell (E); (C) electron dense material (arrowhead) in the intercellular
space between epithelial cells (E); (D) swollen desmosomes (D) full of dense material in an
epithelial cell (E) and abnormal proteoglycan (PG) in basement membrane (BM); (E) large
abnormal proteoglycan (PG) in pre-Descemet’s stroma (S); (F) vacuolated keratocytes (KR) in a
degenerate lamella (LM); (G) part of a degenerate keratocyte (KR) showing accumulation of
proteoglycan (PG) in a lysosome (LY).
Clinical and morphological features in Maroteaux-Lamy syndrome type B and in normal cornea 149
www.bjophthalmol.com
 on 15 November 2005 bjo.bmjjournals.comDownloaded from 
cannot be degraded and cleared from the cell, therefore accu-
mulate in the lysosomes, eventually causing cell death.Mono-
clonal antibody 5-D-4 recognises oversulphated domains in
keratan sulphate GAGs (the major GAG on proteoglycans in
the cornea), so the heavy keratan sulphate labelling seen in
the lysosomes and vacuoles represents the GAG that has
accumulated over time. In the cornea, the candidate prote-
oglycans for 5-D-4 labelling are the so called “small leucine
rich proteoglycans” lumican and fibromodulin, each of which
has three or four (lumican) or two or three (fibromodulin)
keratan sulphate chains attached22 and both of which act to
regulate collagen fibrillogenesis. It is therefore an accumula-
tion of one or both of these PGs that is visualised with mono-
clonal antibody 5-D-4.23
The greater quantity of keratan sulphate labelling in the
posterior keratocytes and the posterior stroma may be due to
Figure 3 Immunolocalisation of
βig-h3 in MLS type B cornea. (A) Very
strong labelling around lucent spaces
(L) in the stroma (S); (B) strong
labelling around a keratocyte (KR) but
not in the keratocyte.
Figure 4 Immunolocalisation of
keratan sulphate (KS) with MAB 5-D-4
in normal and MLS type B cornea. (A)
Regular labelling of KS on collagen
fibres in normal cornea; (B) strong
labelling of KS in clumps on stromal
collagen fibres (S) in MLS type B
cornea; (C) very strong labelling of
KS around lucent spaces (L) in the
stroma (S) of MLS type B cornea; (D)
moderate labelling of KS in a normal
keratocyte (KR); (E) “empty”
keratocyte (KR) in MLS type B cornea
containing a lysosome (LY); (F) strong
labelling of KS in the lysosome (LY)
shown in (E); (G) labelling of KS in
the endothelium (EN) of MLS type B
cornea.
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differences in the relative cell populations of the different
regions. Since the accumulation of GAGs eventually kills the
cells, over time the ability to supply the matrix with new PGs
would be compromised.
Our data suggest that in this patient there was an intracy-
toplasmic accumulation of keratan sulphate, together with
other GAGs, presumably due to the deficiency of aryl sulfatase
B, which catabolises GAGs. This GAG accumulation seems to
have led to degeneration and enlargement of keratocytes, fol-
lowed by an abnormal build-up of proteoglycans in the
stroma, disorganisation of collagen fibrils, and disruption of
the parallel arrangement of collagen lamellae. A secondary
effect of oedematous stroma involved degeneration of the epi-
thelium, which contained cells with apoptotic nuclei, and
accumulation of βig-h3 protein in the stroma. The gross
changes in the epithelial, stromal, and endothelial cells and
the disruption of the collagen would be expected to increase
light scattering significantly and thus cause the cornea to
become opaque.
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